Business review·
A Billion-Dollar Brand No One Noticed, Built by Two Founders in Just Three Years
Jungle Scout, Helium 10, and SmartScout estimates WEEM’s annual Amazon sales at approximately $75 million. Yet Amazon may be the company’s smaller channel. It ranked #1 Best Seller for 36 months despite limited investment in Amazon advertising, while its Meta Ad Library footprint is unusually active for such a lean team and leadership structure. Recent trademark and domain filings also point to potential interest in telehealth. The question is: where is this little known growth engine heading next?
By Denise Stamell

I found WEEM while reviewing Amazon’s Top 100 in Vitamins, Minerals & Supplements.
It ranks #1 in its Amazon subcategory and 5th in the Top 100 supplements ranking. Historical ranking data available through Jungle Scout, Helium 10, and SmartScout showed that WEEM has been #1 for the last three years.
Its listing has more than 30,000 customer reviews.
That was enough to make the company worth examining more closely.
I asked around. DTC analysts, supplement industry contacts, retail buyers. Nobody had heard of it.
So I started pulling the thread.
The Amazon Numbers
Best-seller rankings are public. Anyone can see them. Estimation tools carry a margin of error, but when three independent platforms return the same range, the signal is reliable.
WEEM’s Amazon revenue appears to land in the range of $70 million to $75 million annually, with a visible spike in Q4, consistent with holiday purchasing patterns. That is a large number. It is not the interesting number.
The Ad Spend That Isn’t There
I searched Sponsored Products for every competitive keyword in WEEM’s category: “gummies,” “vitamins,” and “supplements,” among many other terms. WEEM didn’t appear. The search was conducted at different times, from multiple locations and devices, with consistent results.
The only keyword they bid on was their own name.
That distinction matters in a highly competitive category. Nature Made, produced by Pharmavite, part of Otsuka Pharmaceutical, One A Day, a Bayer brand, and Garden of Life that was acquired by Nestlé in 2018, also appear among Amazon’s Top 100 supplement products.
An external model of branded search activity, reviewed by an Amazon advertising specialist, estimated WEEM’s Amazon brand defense spend at approximately $2,000 to $4,000 per day. The estimate combines sponsored placements, third-party keyword volume data, and specialist-reviewed assumptions for click-through rates and cost per click.
Third-party benchmarks for established supplement brands commonly place total Amazon advertising investment at roughly 12% to 18% of marketplace sales. At WEEM’s estimated Amazon sales level, that would equate to approximately $20,000 to $37,000 per day in total advertising spend. WEEM spends a tenth of that.
“That’s not an advertising strategy,” the specialist said. “That’s name protection. The actual sales are coming from somewhere else.”
Amazon advertising specialist, interviewed on background
The Meta Operation
I checked the Meta Ad Library, a free public database. It revealed a different picture.
WEEM had hundreds of active creatives running simultaneously. Dozens of formats. Multiple ad accounts.
Three independent media buyers I consulted said the activity was consistent with a large-scale paid social program, rather than occasional campaign activity.
None of these ads pointed to Amazon. They all drove to WEEM’s own website.
So here is the picture: Amazon generates an estimated $70 million to $75 million a year, and Amazon appears to be the smaller channel. I’ll let readers do the arithmetic.
Five People and Two Leaders
I checked LinkedIn. Two founders: Eli Cohen and Mendel Weinberger. Fewer than five other employees were visible.
I searched Indeed, Glassdoor, and ZipRecruiter. No job postings. No historical listings. No careers page on the Wayback Machine. None had ever existed.
I searched SEC EDGAR, Crunchbase, and PitchBook. No funding record of any kind. No venture capital. No angel round.
Every dollar of that Meta spend appears to come from revenue the business has already generated.
The Starting Capital
In researching the founders’ backgrounds, I came across a LinkedIn post from Cohen that referenced starting the company with $60,000 in personal savings. I could not independently verify the figure through any other source, and the founders did not respond to requests for comment. What I can confirm is that no external funding has ever been recorded.
If the $60,000 figure is accurate, the return on that initial investment is almost difficult to comprehend.
What Might Be Next
The last thing I found was the detail that made me write this.
Trademark filings and domain registrations linked to WEEM’s ownership structure suggest the company is building something in healthcare, telehealth, preventive care, or both.
If true, the same two founders who built the #1 Amazon supplement brand from $60,000 with no team and no investors are now pointing that model at an industry where the incumbents have spent billions building walls that are supposed to be unclimbable.
I reached out to both founders for comment. Neither responded.
But when I checked their website one last time before publishing, I noticed something that hadn’t been there before: a careers page.
It appears that WEEM is hiring. See WEEM's job opportunities here.
Methodology
- Marketplace-sales estimates were compiled from Jungle Scout, Helium 10, and SmartScout and should be treated as third-party estimates, not company-reported financial results.
- Amazon sponsored placement observations reflect a defined set of searches conducted manually.
- Meta Ad Library findings reflect publicly visible active ads and destination links, not advertising spend, return on ad spend, audience targeting, or internal account structure.
- LinkedIn findings reflect publicly visible profiles. Funding research reviewed Crunchbase, PitchBook, and available public corporate records.
- Trademark information was reviewed through public filing databases.
- No proprietary company information was used.